RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-4319
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_0809400; Gene model (P.falciparum): PF3D7_0908000; Gene product: plasma membrane protein 1, putative (PMP1)
Name tag: GFP
Transgene
Transgene not Plasmodium: mCherry
Promoter: Gene model: PBANKA_1133300; Gene model (P.falciparum): PF3D7_1357100; Gene product: elongation factor 1-alpha (eef1a)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Insertion locus: Gene model: Not available; Gene product: Not available (small subunit ribosomal rna gene (c-type unit))
Phenotype Asexual bloodstage; Gametocyte/Gamete; Fertilization and ookinete; Oocyst; Sporozoite; Liver stage;
Last modified: 10 September 2017, 16:39
  *RMgm-4319
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 28851956
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherBurda PC; Heussler VT
Name Group/DepartmentInstitute of Cell Biology
Name InstituteUniversity of Bern
CityBern
CountrySwitzerland
Name of the mutant parasite
RMgm numberRMgm-4319
Principal namePbPMP1-GFP
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageWe first examined PbPMP1-GFP blood stage parasites. Here, although rather weak, the GFP signal was found to surround the cytoplasmic mCherry signal in trophozoites, merozoites and gametocytes, suggesting that PbPMP1-GFP also localizes to the parasite plasma membrane (PPM) during blood stage development. This finding was confirmed by IFA of blood stage schizonts, where PbPMP1 was co-localizing with the plasma membrane marker MSP1.
Gametocyte/GameteWe first examined PbPMP1-GFP blood stage parasites. Here, although rather weak, the GFP signal was found to surround the cytoplasmic mCherry signal in trophozoites, merozoites and gametocytes, suggesting that PbPMP1-GFP also localizes to the parasite plasma membrane (PPM) during blood stage development. This finding was confirmed by IFA of blood stage schizonts, where PbPMP1 was co-localizing with the plasma membrane marker MSP1.
Fertilization and ookinetePbPMP1 was also localized at the PPM of ookinetes, in which PbPMP1-GFP was additionally located in intracellular dots, possibly representing newly synthesized PbPMP1 during transport to the plasma membrane.
OocystWe analyzed the development of PbPMP1-GFP oocysts at 7, 9 and 11 days post mosquito infection. We observed a strong GFP signal in the periphery of all oocysts without any signs of invagination at day 7 post-infection, indicating that PbPMP1-GFP also labels the PPM in this parasite stage. at 9 and 11 days after the infectious blood meal, PbPMP1-GFP started to form a seemingly interconnected network within oocysts. The nuclei were thereby found to align along the newly formed membranes, at sites where subsequent sporozoite formation was initiated. Finally, PbPMP1-GFP was surrounding individual sporozoites within oocysts, which still contained portions of cytoplasmic material that had not been incorporated into forming sporozoites, these presumably being the formerly described residual bodies.
SporozoiteIn isolated salivary gland sporozoites and transforming sporozoites inside host HeLa cells, PbPMP1-GFP was similarly found at the parasite periphery, although the fluorescence was much weaker as compared to oocysts
Liver stageIFA revealed that PbPMP1-GFP co-localized with the PPM marker MSP1 but not with exported protein 1 (EXP1), which was used to visualize the PVM. Expression of PbPMP1-GFP did not influence the development of parasites, as PbPMP1-GFP parasites showed normal numbers of sporozoites in the salivary glands and progressed normally through liver stage development.
Additional remarks phenotype

Mutant/mutation
The mutant expresses a C-terminal GFP-tagged version of PMP1. The pmp1 gene is under control of the constitutive eef1a promoter and is introduced into the silent c/d-rRNA gene unit. In addition the parasite expresses mCherry under the control of the eef1a promoter.

Protein (function)
P. berghei Plasma Membrane Protein 1 (PbPMP1) is a 404 amino acids protein, which is conserved among Plasmodium species and contains a predicted phospholipase C/P1-S1 nuclease domain in addition to a signal peptide and a C-terminal transmembrane domain An RNAseq study, primarily of blood stage P. berghei parasites, showed highest expression of PbPMP1 in schizont stages, in comparison to rings, trophozoites, gametocytes and ookinetes18. Furthermore, PbPMP1- derived peptides were detected in a study comparing the proteome of male and female gametocytes, indicating expression at this stage.
A mutant lacking expression of PMP1 shows normal development throughout the complete life cycle (see RMgm-4320).

Phenotype
See also mutant RMgm-4320 which lacks expression of PMP1 and shows normal development throughout the complete life cycle.

PMP1 was located at the parasite plasma membrane (PPM) in all life cycle stages (see above for more details).

Additional information

Other mutants
RMgm-4320 - A mutant lacking expression of PMP1 and expressing mCherry under the control of the P. berghei hsp70 promoter
 


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0809400
Gene Model P. falciparum ortholog PF3D7_0908000
Gene productplasma membrane protein 1, putative
Gene product: Alternative namePMP1
Details of the genetic modification
Name of the tagGFP
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid single cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe mutant expresses a C-terminal GFP-tagged version of PMP1. The pmp1 gene is under control of the constitutive eef1a promoter and is introduced into the silent c/d-rRNA gene unit. In addition the parasite expresses mCherry under the control of the eef1a promoter.

The PbPMP1-GFP expression vector pL0017CPbPMP1-GFPCmCherry was generated by first amplifying the PbPMP1 coding sequence from blood stage cDNA using primer pair PbPMP1-GFP-fw/PbPMP1-GFP-rev and this was subsequently cloned into pL0017 in frame with GFP using BamHI restriction sites. Subsequently, a constitutive mCherry expression cassette, which had been amplified before from the pCmCherry plasmid using primers eef1a-fw and 3dhfr-rev, was integrated using KpnI restriction sites
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene namemCherry
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid single cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1133300
Gene Model P. falciparum ortholog PF3D7_1357100
Gene productelongation factor 1-alpha
Gene product: Alternative nameeef1a
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionInsertion locus
Gene Model of Parasite Not available
Gene productNot available
Gene product: Alternative namesmall subunit ribosomal rna gene (c-type unit)
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4